Shariat SF - Search Results

1

Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer.

Piccinelli ML, Luzzago S, Marvaso G, Laukhtina E, Miura N, Schuettfort VM, Mori K, Colombo A, Ferro M, Mistretta FA, Fusco N, Petralia G, Jereczek-Fossa BA, Shariat SF, Karakiewicz PI, de Cobelli O, Musi G. Piccinelli ML, et al. Among authors: shariat sf. World J Urol. 2022 Jun;40(6):1447-1454. doi: 10.1007/s00345-022-03983-8. Epub 2022 Mar 26. World J Urol. 2022. PMID: 35347414 Free PMC article.

2

Prostate specific antigen density of the transition zone for early detection of prostate cancer.

Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC, Marberger M. Djavan B, et al. J Urol. 1998 Aug;160(2):411-8; discussion 418-9. J Urol. 1998. PMID: 9679889

3

Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?

Djavan B, Shariat S, Ghawidel K, Güven-Marberger K, Remzi M, Kovarik J, Hoerl WH, Marberger M. Djavan B, et al. Urology. 1999 Jun;53(6):1169-74. doi: 10.1016/s0090-4295(99)00010-2. Urology. 1999. PMID: 10367847 Clinical Trial.

4

Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer.

Gore JL, Shariat SF, Miles BJ, Kadmon D, Jiang N, Wheeler TM, Slawin KM. Gore JL, et al. Among authors: shariat sf. J Urol. 2001 May;165(5):1554-9. J Urol. 2001. PMID: 11342916

5

Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.

Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM. Shariat SF, et al. Urology. 2001 Dec;58(6):1008-15. doi: 10.1016/s0090-4295(01)01405-4. Urology. 2001. PMID: 11744478

6

Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.

Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Singh H, et al. Among authors: shariat sf. J Urol. 2004 Jan;171(1):204-9. doi: 10.1097/01.ju.0000100220.46419.8b. J Urol. 2004. PMID: 14665877

7

Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.

Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Singh H, et al. Among authors: shariat sf. J Urol. 2004 Mar;171(3):1089-92. doi: 10.1097/01.ju.0000112763.74119.d4. J Urol. 2004. PMID: 14767277

8

Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy.

Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Sagalowsky AI, Cadeddu JA, McConnell JD, Holmes MN, Roehrborn CG. Shariat SF, et al. J Urol. 2004 Mar;171(3):1122-7. doi: 10.1097/01.ju.0000113249.82533.28. J Urol. 2004. PMID: 14767284

9

Predictors of prostate cancer after initial negative systematic 12 core biopsy.

Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Singh H, et al. Among authors: shariat sf. J Urol. 2004 May;171(5):1850-4. doi: 10.1097/01.ju.0000119667.86071.e7. J Urol. 2004. PMID: 15076292

10

The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.

Lotan Y, Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Cadeddu JA, Sagalowsky AI, McConnell JD, Roehrborn CG. Lotan Y, et al. Among authors: shariat sf. J Urol. 2004 Jun;171(6 Pt 1):2209-14. doi: 10.1097/01.ju.0000127730.78973.fe. J Urol. 2004. PMID: 15126787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,929 results

Search Page

Filters